Pivotal Phase III Clinical Trial of Presendin™ (Sustained-Release Exenatide) versus placebo in Idiopathic Intracranial Hypertension (IIH)

Trial Steering Group Chairperson – Professor Michael Wall


Michael Wall, M.D. is a professor of Neurology and Ophthalmology at the University of Iowa. His undergraduate and medical school education was at Tulane University, his neurology residency at Washington University in St. Louis and fellowship at Harvard University.

As a neuro-ophthalmologist he is involved in patient care, teaching and research. He is the author of 124 peer-reviewed journal articles and three books. He has been involved in idiopathic intracranial hypertension research for 30 years and was the Study Director of the NIH funded Idiopathic Intracranial Hypertension Treatment Trial. He had consecutive funding for over 25 years through the VA Merit system. This research focused on development of new and improved perimetric methods and strategies and mechanisms of perimetric variability.

He is the director of the Iowa Visual Field Reading Center, established in 2008. The reading center features a fully digital secure system. Its goal is to provide researchers a means to access and evaluate both raw and processed visual field data and to provide timely feedback to researchers and clinicians. The reading center has been involved in successfully completing 12 clinical trials involving both the NIH and pharma.